MedTrace Logo

Clinical Trial to Evaluate of Efficacy and Safety of Ginsengberry Concentrate on Fatigue.

NCT05725044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2023-05-26

No results posted yet for this study

Summary

The investigators conduct a 8-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ginsengberry concentrate on fatigue.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ginsengberry concentrate

Ginsengberry concentrate

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Inha University Hospital

    collaborator OTHER

  • Amorepacific Corporation

    lead INDUSTRY

Principal Investigators

  • Kyung Lim Joa, Dr · Inha University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-13
Primary Completion
2023-03-03
Completion
2023-05-03

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05725044 on ClinicalTrials.gov